Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study - Archive ouverte HAL Access content directly
Journal Articles European Journal of Cancer Year : 2021

Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study

(1) , (2) , , (3) , (4) , (5, 6) , (7) , (8) , (9) , (10) , (11) , (12) , (13) , (14) , , (15) , (16) , (17) , (18) , (1) , , ,
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Antoine Italiano
Emannuelle Bompas
  • Function : Author
Nicolas Penel
Laure Monard
Vincent Vidal
  • Function : Author
Sylvie Chabaud
  • Function : Author
Jean-Yves Blay

Dates and versions

hal-03623638 , version 1 (29-03-2022)

Identifiers

Cite

Florence Duffaud, Antoine Italiano, Emannuelle Bompas, Maria Rios, Nicolas Penel, et al.. Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study. European Journal of Cancer, 2021, 150, pp.108-118. ⟨10.1016/j.ejca.2021.03.039⟩. ⟨hal-03623638⟩
13 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More